Status:
UNKNOWN
Impact of the Comprehensive Geriatric Assessment on the Quality of Life OF Elderly Patients
Lead Sponsor:
Lorenza Scotti
Conditions:
Hematologic Malignancies
Solid Tumor
Eligibility:
All Genders
65+ years
Brief Summary
Impact of the Comprehensive Geriatric Assessment on the Quality of Life of elderly onco-hematologic patients' candidates for complex antitumoral therapies: clinical and biological correlatives
Detailed Description
The screenings for the next 2 decades indicate an exponential increase in the incidence of neoplastic diseases in the elderly population. In order to successfully balance effectiveness and low toxicit...
Eligibility Criteria
Inclusion
- Patients aged ≥ 65 years
- Diagnosis of solid or hematologic cancer
- Patients who are candidates for a first line therapy for advanced disease to be treated with biological target drugs, or candidates for integrated radiotherapy
- Patient with G8 scores ≤ 14/17
Exclusion
- Patients aged less than 65 years
- Patients who have received or currently in treatment for solid or hematologic cancer
- Patient with G8 scores more than 14/17
Key Trial Info
Start Date :
December 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT04478916
Start Date
December 18 2019
End Date
May 1 2022
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Università del Piemonte Orientale - Azienda Ospedliero-Universitaria Maggiore della Carita'
Novara, Italy, 28100